PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

glycopyrrolate

Verify with FDA → · CMS NADAC pricing →

Brand names: Seebri, Lonhala

Long-Acting Muscarinic Antagonist (LAMA) Rx

Glycopyrrolate injection reduces body secretions before and during surgery. It can also help manage peptic ulcers in adults when quick action is needed.

Drug Pricing (NADAC)

Generic Price

$1.40/unit

Generic Available

Yes (38 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

What it does

This medicine can help reduce saliva and other secretions before surgery.

Common side effects

Dry mouth, Trouble urinating, Blurred vision

Key warnings

This medicine contains benzyl alcohol, which can be harmful to newborns.

How It Works

Glycopyrrolate blocks the action of a chemical called acetylcholine. This chemical can cause increased saliva, stomach acid, and other body fluids. By blocking acetylcholine, glycopyrrolate reduces these secretions.

How to Take It

A healthcare provider will give you this medicine as an injection into a muscle or vein. The dose depends on why you are getting the medicine. For peptic ulcers, the usual dose is 0.1 mg every 4 hours, 3 to 4 times a day.

Pregnancy & Breastfeeding

Tell your doctor if you are pregnant or breastfeeding. It is not known if glycopyrrolate will harm an unborn baby. This medicine may also reduce breast milk production.

Missed Dose

Since a healthcare provider is giving you this medicine, you are unlikely to miss a dose. Call your doctor if you have concerns.

Storage

Store at room temperature, away from heat and light.

Side Effects (from patient reports)

Based on 5,420 FDA adverse event reports.

Difficulty breathing
1,000
Asthma
793
Wheezing
674
Cough
626
Pneumonia
538
Drug not working
411
Tiredness
352
Using the drug for an unapproved purpose
351
Feeling unwell
345
Cough with mucus
330

FDA Adverse Event Report Analysis

Detailed analysis of 5,225 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2001–2025.

Total Reports

5,225

Death-Related Reports

630

Hospitalization Reports

2,218

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 2,550 (55%)
Male 2,055 (44%)

Age Distribution

0–17 450
18–44 765
45–64 1,066
65–74 753
75+ 592

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 DYSPNOEA 1,000
2 ASTHMA 793
3 WHEEZING 674
4 COUGH 626
5 PNEUMONIA 538
6 DRUG INEFFECTIVE 411
7 FATIGUE 352
8 OFF LABEL USE 351
9 MALAISE 345
10 PRODUCTIVE COUGH 330
11 CHEST DISCOMFORT 327
12 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 326
13 CONDITION AGGRAVATED 311
14 NAUSEA 311
15 PYREXIA 304

Reactions in Death Reports

DEATH 237
PNEUMONIA 56
DYSPNOEA 50
OFF LABEL USE 49
RESPIRATORY FAILURE 47
CARDIAC ARREST 36
DISEASE PROGRESSION 35
ASTHENIA 34
DIARRHOEA 30
CHRONIC OBSTRUCTIVE PULMONARY DISEASE 28

Reactions in Hospitalization Reports

DYSPNOEA 524
ASTHMA 413
PNEUMONIA 397
WHEEZING 388
COUGH 267
CHRONIC OBSTRUCTIVE PULMONARY DISEASE 252
CONDITION AGGRAVATED 200
FATIGUE 198
NAUSEA 193
CHEST DISCOMFORT 191

Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

This medicine contains benzyl alcohol, which can be harmful to newborns. If you have glaucoma, trouble urinating, or a blockage in your stomach or intestines, you should not take this medicine for peptic ulcer treatment.

Known Drug Interactions

Concomitant administration of glycopyrrolate injection and potassium chloride in a wax matrix may increase the severity of potassium chloride-induced gastrointestinal lesions as a result of a slower gastrointestinal transit time.

Mechanism: Glycopyrrolate slows down your digestion, which can cause potassium tablets to sit in your stomach or intestines too long and cause sores.

What to do: Talk to your doctor about this combination and report any new stomach pain or digestive issues immediately.

No significant adverse interactions with commonly used premedications or drugs used during anesthesia and surgery (including atropine, scopolamine, glycopyrrolate, diazepam, hydroxyzine, d-tubocurarine, succinylcholine and other nondepolarizing muscle relaxants) or topical local anesthetics (including lidocaine, dyclonine HCl and Cetacaine) have been observed in adults or pediatric patients.

Mechanism: These drugs do not have any known harmful interactions when used together during surgery or anesthesia.

What to do: This combination is considered safe to use, and no special changes are needed.

Common Questions

What should I tell my doctor before taking glycopyrrolate?
Tell your doctor if you have any allergies, glaucoma, urinary problems, or stomach problems.
Can I take glycopyrrolate with other medicines?
Tell your doctor about all the medicines you take, including over-the-counter drugs and supplements.
What are the signs of an allergic reaction?
Signs of an allergic reaction include rash, itching, swelling, dizziness, and trouble breathing.
Can glycopyrrolate cause mental confusion?
Yes, especially in elderly people.
What should I do if I experience severe side effects?
Contact your doctor immediately if you experience severe side effects.
Is glycopyrrolate safe for children?
Glycopyrrolate injection is not recommended for treating peptic ulcers in children.
How is glycopyrrolate given?
It is given as an injection into a muscle or vein.
Can glycopyrrolate affect my vision?
Yes, it can cause blurred vision.
Can glycopyrrolate cause constipation?
Yes, constipation is a common side effect.
Who makes this medicine?
Meitheal Pharmaceuticals makes this medicine.
What are the common side effects of glycopyrrolate?
The most commonly reported side effects of glycopyrrolate include Dry mouth, Trouble urinating, Blurred vision, Increased heart rate, Decreased sweating. Based on 5,420 FDA adverse event reports. Always consult your healthcare provider about potential side effects.
Does glycopyrrolate interact with other medications?
Yes, glycopyrrolate has 2 known drug interactions. Notable interactions include potassium chloride, midazolam. Always inform your doctor about all medications you are taking.
What drug class is glycopyrrolate?
glycopyrrolate belongs to the Long-Acting Muscarinic Antagonist (LAMA) drug class. It requires a prescription (Rx). This medicine can help reduce saliva and other secretions before surgery.
Is glycopyrrolate safe during pregnancy?
Tell your doctor if you are pregnant or breastfeeding. It is not known if glycopyrrolate will harm an unborn baby. Always consult your healthcare provider before using any medication during pregnancy or breastfeeding.

Related Medications in Long-Acting Muscarinic Antagonist (LAMA)

Other drugs grouped near glycopyrrolate — same-class peers and common alternatives.

Compare glycopyrrolate vs aclidinium side-by-side →

Medication Guides

Related Health & Safety Data

Save on glycopyrrolate

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for glycopyrrolate

The FDA label for glycopyrrolate (sold under brand names such as Seebri, Lonhala) classifies it as a prescription-only medication in the Long-Acting Muscarinic Antagonist (LAMA) class. This medicine can help reduce saliva and other secretions before surgery. Official labeling lists 15 commonly reported side effects, including Dry mouth, Trouble urinating, Blurred vision.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 5,420 voluntary reports. The database also lists 2 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated minor severity. NADAC pricing from CMS shows a generic unit cost of $1.40.

Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.

Last updated: November 18, 2025

All federal data sources used on this page